Alfuzosin Hydrochloride

Product NDC
69097-844
11-digit product format
690970844
Labeler code
69097
Product ID
69097-844_497e0a60-9b09-4dcc-8cc6-1f13196f2db4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Alfuzosin Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Cipla USA Inc.
Application
ANDA090284
Marketing category
ANDA
Marketing start
2016-06-30
Substance
ALFUZOSIN HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A090284-001ALFUZOSIN HYDROCHLORIDEALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A090284-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-1774a2ff9319b5…
2022-03-09 01:35 UTC2022-03A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-1787673890dc5c…
2021-03-12 10:30 UTC2021-03A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-175aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-178869cabd3fbd…
2020-11-12 02:37 UTC2020-11A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17c0c555d07b60…
2019-12-14 00:12 UTC2019-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-173f01610625f2…
2019-09-15 20:21 UTC2019-09A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17b00525d2431f…
2019-07-19 19:46 UTC2019-07A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-176a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-171c564ffb4f44…
2023-12-20 04:57 UTC2023-12A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-179b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-173f0d92c62455…
2023-05-13 08:27 UTC2023-05A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17053a50430f4f…
2023-01-26 05:58 UTC2023-01A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-173bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-173a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A090284-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2012-01-17cb3db0bc1861…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A090284-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090284-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A090284-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090284-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090284-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090284-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090284-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090284-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090284-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090284-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090284-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090284-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090284-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090284-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090284-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090284-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090284-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090284-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A090284-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A090284-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A090284-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A090284-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A090284-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A090284-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A090284-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A090284-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A090284-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A090284-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A090284-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A090284-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A090284-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A090284-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A090284-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A090284-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A090284-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A090284-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A090284-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A090284-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A090284-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A090284-001AB1cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Alfuzosin Hydrochloride
Brand name suffix
extended release
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ALFUZOSIN HYDROCHLORIDE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
75046A1XTNInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
861132Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
3cc028d5-309f-4ce3-a2d7-5804ab57677dAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8b671e1a-6f8a-5de4-69a7-83132df7952dProduct name320201015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69097-844-02Alfuzosin Hydrochlorideextended release30 in 1 BOTTLETABLET304
69097-844-05Alfuzosin Hydrochlorideextended release90 in 1 BOTTLETABLET904
69097-844-07Alfuzosin Hydrochlorideextended release100 in 1 BOTTLETABLET1004
69097-844-12Alfuzosin Hydrochlorideextended release500 in 1 BOTTLETABLET5004

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69097-844-07EA - Each69097-844e77c0292-3c7e-4745-9842-0ec4f2ed029d12016-07-19
69097-844-12EA - Each69097-844abb94301-dbff-4c0d-80c6-792120c75ac512016-07-19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69097-844ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE (ALFUZOSIN HYDROCHLORIDE) TABLET [CIPLA USA INC.]4Current NDC, Legacy NDC, 4 package rows20201008_3cc028d5-309f-4ce3-a2d7-5804ab57677d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alfuzosin hydrochlorideALFUZOSIN HYDROCHLORIDEExelan Pharmaceuticals Inc.f075a897-7bef-4799-b7e2-7e051c4614432023-10-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090284
application number: ANDA090284
Alfuzosin Hydrochloride extended releaseALFUZOSIN HYDROCHLORIDECipla USA Inc.3cc028d5-309f-4ce3-a2d7-5804ab57677d2020-10-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090284
application number: ANDA090284
ndc (product): 69097-844
Alfuzosin hydrochlorideALFUZOSIN HYDROCHLORIDEAphena Pharma Solutions - Tennessee, LLC790fe381-4a83-402e-b6c0-2ecde9cac7a72017-12-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090284
application number: ANDA090284

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN3cc028d5-309f-4ce3-a2d7-5804ab57677d4
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD3cc028d5-309f-4ce3-a2d7-5804ab57677d4
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY3cc028d5-309f-4ce3-a2d7-5804ab57677d4

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
69097-844-026909708440230 TABLET in 1 BOTTLE (69097-844-02) 30 tablet2016-06-300000-00-00NoNoCurrent
69097-844-056909708440590 TABLET in 1 BOTTLE (69097-844-05) 90 tablet2016-06-300000-00-00NoNoCurrent
69097-844-0769097084407100 TABLET in 1 BOTTLE (69097-844-07) 100 tablet2016-06-300000-00-00NoNoCurrent
69097-844-1269097084412500 TABLET in 1 BOTTLE (69097-844-12) 500 tablet2016-06-300000-00-00NoNoCurrent